Quarantine Notice – Sodium Chloride ampoules

Posted November 27, 2023

The PHN is informing primary care providers that on 24/11/2023, the Public Health and Surveillance Branch in the Office of Health Protection of the Department of Health and Aged Care has issued a quarantine notice for the following product:

InterPharma Sodium Chloride 0.9% 10ml or 30ml ampoules.

The sponsor of the product will contact affected customers.

These products should be removed from use immediately and placed in quarantine until further notice.

The quarantine notice was released after several reported cases of Ralstonia pickettii in multiple jurisdictions, a pathogen with nosocomial significance.

For further questions, download the quarantine notice and contact details.

Explore more news like this:

More about:

HNECC PHN Announcement Pharmacy

For audiences:

General Practitioner Health Professionals Pharmacist

Keep up to date with the latest.

Subscribe to our mailing list to get all the latest news updates delivered to your inbox.

First Name

Last Name

Your Email Address

Which area from our region do you live/work?

Related News

March 04 2024

Supporting Digital Health Change - Survey

Engage with the PHN’s Health-e Together Digital Care Toolbox: Your Insights Matter

Hunter New England and Central Coast Primary Health Network (the PHN) continues its commitment to advancing digital health initiatives to support the primary healthcare workforce. Your insights are crucial in shaping how we communicate the future of digital healthcare delivery, and we believe your perspective will greatly contribute to the success of our efforts.

June 22 2023

Changes for Opioid Dependence Treatment (ODT) medicines

From 1 July 2023, ODT medicines will become part of the Section 100 Highly Specialised Drugs (HSD) Program (Community Access) arrangements. This means ODT medicines will be dispensed in the same way as other community access Section 100 HSD Program medicines from section 90 approved community pharmacies, section 92 approved medical practitioners, and section 94 approved hospital authorities (public and private).

June 30 2023

Diversity Inclusion and Belonging a Priority for the PHN

In 2022, the PHN developed its 2022-2025 Diversity, Inclusion and Belonging Strategy. The strategy is critical to delivering the PHN’s community, workforce and cultural objectives and aligns to the PHN’s strategic purpose of “keeping people well in our communities through innovation, performance, collaboration and local engagement.”